RESEARCH FEATURE
The project might pave the way for new and improved treatments for a wide variety of respiratory diseases
Article published on the website of the National Heart, Lung, and Blood Institute (NHLBI), a US Department of Health and Human Services agency (accessed on January 18, 2020).
Welcome to the Molecular Atlas of Lung Development Program, or LungMAP, a historic effort to help researchers navigate the complex, poorly understood landscape of the human lung. The project aims to create the world’s first comprehensive map of the dynamic molecular and cellular architecture of the developing lung. Researchers say a deeper understanding of these features could lead to better diagnoses and treatments for a variety of respiratory diseases, including asthma, COPD, cystic fibrosis, and bronchopulmonary dysplasia (BPD).
Funded by the National Heart, Lung, and Blood Institute (NHLBI), the project promises to “open the door to a new era in lung research,” says Sara Lin, Ph.D., program director of the Lung Development and Regenerative Biology Program at the NHLBI and LungMAP’s program officer.
LungMAP is basically an interactive, multifaceted web-based tool that provides researchers, educators, and clinicians a centralized way to collect, analyze, and visualize data about the structure and function of the myriad molecules, genes, cells, and tissues that make up the developing lung, including its hidden interconnections. [...]
Read the full article on the NIH website by clicking here.
19/01/2020